Package 47781-419-04

Brand: buprenorphine transdermal system

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 47781-419-04
Digits Only 4778141904
Product NDC 47781-419
Product ID 47781-419_7f83c8aa-7590-e2fe-4998-55323eadd112
Description

4 POUCH in 1 CARTON (47781-419-04) / 1 PATCH in 1 POUCH (47781-419-11) / 168 h in 1 PATCH

Marketing

Marketing Status
Discontinued 2027-01-31
Brand buprenorphine transdermal system
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

buprenorphine transdermal system ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TRANSDERMAL"], "spl_id": "7f83c8aa-7590-e2fe-4998-55323eadd112", "openfda": {"nui": ["N0000175689", "N0000175685"], "unii": ["40D3SCR4GZ"], "rxcui": ["904870", "904876", "904880", "1432969"], "spl_set_id": ["315284b8-32ab-d34a-ea02-f501c6131bcc"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 POUCH in 1 CARTON (47781-419-04)  / 1 PATCH in 1 POUCH (47781-419-11)  / 168 h in 1 PATCH", "package_ndc": "47781-419-04", "marketing_end_date": "20270131", "marketing_start_date": "20220829"}], "brand_name": "buprenorphine transdermal system", "product_id": "47781-419_7f83c8aa-7590-e2fe-4998-55323eadd112", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "47781-419", "dea_schedule": "CIII", "generic_name": "buprenorphine", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "buprenorphine transdermal system", "active_ingredients": [{"name": "BUPRENORPHINE", "strength": "15 ug/h"}], "application_number": "ANDA207490", "marketing_category": "ANDA", "marketing_end_date": "20270131", "marketing_start_date": "20220517"}